Financial Statements — PLSM
Balance Sheet
(in millions ILS)| Metric | FY
2025 |
|---|
| Cash & Equivalents | 21.60 |
| Inventory | 19.93 |
| Total Current Assets | 25.52 |
| Total Non-current Assets | 6.41 |
| Total Assets | 101.85 |
| Total Current Liabilities | 10.33 |
| Total Non-current Liabilities | 8.43 |
| Total Liabilities | 18.76 |
| Retained Earnings | (183.14) |
| Total Stockholder Equity | 26.05 |
Income Statement
(in millions ILS) (except per-share rows)| Metric | FY
2025 |
|---|
| Total Revenue | 40.02 |
| Cost of Revenue* | 6.34 |
| Gross Profit | 33.68 |
| Research & Development | 17.35 |
| Selling, General & Admin | 5.23 |
| Interest Expense | 7.23 |
| Pretax Income | (15.85) |
| Tax Provision | 0.00 |
| Net Income | (15.85) |
| Basic EPS | 0.77 |
| Diluted EPS | 0.77 |
* Derived from reported values
Cash Flow Statement
(in millions ILS)| Metric | FY
2025 |
|---|
| Operating Cash Flow | (10.31) |
| Investing Cash Flow | 13.85 |
| Financing Cash Flow | 0.00 |